Drugmaker Developing Abuse-Deterrent Painkiller
Boston (ap) — The San Diego company that makes the powerful new prescription painkiller Zohydro is selling off its migraine therapy business to focus on developing abuse resistant forms of Zohydro.
Zogenix Chief Executive Officer Roger Hawley said the sale will help the company focus on the launch of Zohydro ER while providing capital “to continue the development of two abuse deterrent formulations of Zohydro ER.” The company announced last November it would pursue an abuse-deterrent form of the drug.
Gov. Deval Patrick sought to ban the drug in Massachusetts fearing it would add to a surge of drug overdoses. A federal court blocked the state from enforcing the ban. Patrick said part of his concern is that the drug didn’t come in an abuse resistant form and could be easily crushed and then inhaled or injected. Patrick has since announced new restrictions on the drug.